CDER Oncology Therapeutics Office To Contain Three Divisions
This article was originally published in The Pink Sheet Daily
Executive Summary
One of the divisions will focus on oncology imaging, Medical Policy Director Temple says. The "concept is settled" but the precise make-up of the other two divisions and a timeline for the implementation are not yet set, he says.
You may also be interested in...
CDER Names Deputy Director For Therapeutic Biological Oncology Products
Robert Justice, former director of the GI/coagulation drug products division, joins the therapeutic biological oncology division ahead of FDA’s planned creation of an Office of Oncology Drug Products.
CDER Names Deputy Director For Therapeutic Biological Oncology Products
Robert Justice, former director of the GI/coagulation drug products division, joins the therapeutic biological oncology division ahead of FDA’s planned creation of an Office of Oncology Drug Products.
Oncology Products Office Director Will Be "Appealing" Position
The position of Office of Oncology Drug Products director will be a "very appealing" job for oncology experts, Acting Commissioner Lester Crawford declared during his Aug. 2 luncheon address to the National Press Club